Evaluation of Different Blood Parameters From Endurance Horses Competing at 160 km.
Authors: Ertelt Antonia, Merle Roswitha, Stumpff Friederike, Bollinger Lena, Liertz Sarah, Weber Corinna, Gehlen Heidrun
Journal: Journal of equine veterinary science
Summary
# Editorial Summary: Blood Parameters in 160 km Endurance Competition Researchers analysed venous blood samples from 52 endurance horses before and after a 160 km race to establish which biomarkers differentiate successful finishers from non-starters, stratified by whether elimination occurred due to metabolic or gait-related concerns. Seven parameters were measured—including cardiac troponin I, heart fatty acid binding protein, lactate dehydrogenase, and various arginine metabolites—with particular attention to cardiac stress indicators. Finishers showed significant post-race elevations in LDH, SDMA and ADMA (all P ≤ .001), whilst both finishers and gait-related non-finishers exhibited increased cardiac troponin I and α-HBDH, with these five markers rising proportionally to distance covered. Critically, none of the measured parameters demonstrated diagnostic value in prospectively identifying which horses would fail to complete the race or determine the underlying cause of elimination. For practitioners involved in pre-competition screening or post-race assessment, these findings suggest that standard cardiac and metabolic biomarkers reflect the physiological demand of endurance exertion rather than predicting fitness to compete or identifying underlying pathology—emphasising that clinical assessment, training history and individual fitness evaluation remain essential for informed decision-making at veterinary inspections.
Read the full abstract on PubMed
Practical Takeaways
- •Cardiac biomarkers (cTNI, α-HBDH) and metabolic markers (LDH, SDMA, ADMA) are consistently elevated after 160 km endurance racing regardless of finishing status, indicating these markers reflect exertion rather than predicting failure
- •Pre-race blood values do not appear to differentiate horses that will complete the race from those that will be eliminated for metabolic or gait issues, so blood screening alone cannot predict which horses are at risk
- •Post-race elevation of these parameters correlates with distance completed, suggesting they may be useful for monitoring cumulative metabolic stress during training and competition planning rather than for predicting individual race outcomes
Key Findings
- •LDH, SDMA, and ADMA increased significantly (P=0.001–0.002) after 160 km endurance racing in finishers
- •cTNI and α-HBDH increased significantly in both finishers (P=0.001) and gait-related non-finishers (P=0.002–0.007)
- •Distance completed correlated positively with increases in all five blood parameters measured
- •No significant differences in blood parameters were found between finisher and non-finisher groups before or after racing, limiting predictive value for performance outcome